| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CNNM2 PIEZO1 SLC10A4 SLC25A14 TMC6 STING1 ITGAV RYR3 TRPM5 SLC16A3 SLC15A1 TMC8 CACNA1H SLC39A5 SLC9A6 | 5.56e-05 | 793 | 116 | 15 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CNNM2 PIEZO1 SLC10A4 SLC25A14 STING1 ITGAV RYR3 TRPM5 SLC16A3 SLC15A1 CACNA1H SLC39A5 SLC9A6 | 1.28e-04 | 664 | 116 | 13 | GO:0008324 |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 1.46e-04 | 18 | 116 | 3 | GO:0008381 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CNNM2 PIEZO1 SLC10A4 SLC25A14 TMC6 STING1 ITGAV RYR3 TRPM5 SLC16A4 SLC16A3 SLC15A1 TMC8 GSDMA CACNA1H SLC39A5 SLC9A6 SLC27A2 | 1.54e-04 | 1180 | 116 | 18 | GO:0022857 |
| GeneOntologyMolecularFunction | neuropeptide Y receptor binding | 1.99e-04 | 4 | 116 | 2 | GO:0031841 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CNNM2 SLC10A4 SLC25A14 STING1 ITGAV RYR3 TRPM5 SLC16A3 SLC15A1 CACNA1H SLC39A5 SLC9A6 | 2.90e-04 | 627 | 116 | 12 | GO:0022890 |
| GeneOntologyMolecularFunction | transporter activity | CNNM2 PIEZO1 SLC10A4 SLC25A14 TMC6 STING1 ITGAV RYR3 TRPM5 SLC16A4 SLC16A3 SLC15A1 TMC8 GSDMA CACNA1H SLC39A5 SLC9A6 SLC27A2 | 4.50e-04 | 1289 | 116 | 18 | GO:0005215 |
| GeneOntologyBiologicalProcess | regulation of antibacterial peptide production | 1.42e-05 | 9 | 116 | 3 | GO:0002786 | |
| GeneOntologyBiologicalProcess | regulation of antimicrobial peptide production | 2.77e-05 | 11 | 116 | 3 | GO:0002784 | |
| GeneOntologyBiologicalProcess | antibacterial peptide production | 3.67e-05 | 12 | 116 | 3 | GO:0002778 | |
| GeneOntologyBiologicalProcess | regulation of antimicrobial humoral response | 6.03e-05 | 14 | 116 | 3 | GO:0002759 | |
| GeneOntologyBiologicalProcess | antimicrobial peptide production | 6.03e-05 | 14 | 116 | 3 | GO:0002775 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | NAT8L TAPT1 AUP1 DIPK1A PIEZO1 TMC6 WDR81 DIPK1B XK TMEM214 STING1 CYP2S1 RYR3 PIGQ NBAS TMC8 DISP3 UGT2B28 ALG6 MYMX SLC9A6 SLC27A2 | 2.20e-06 | 1293 | 116 | 22 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | NAT8L TAPT1 AUP1 DIPK1A PIEZO1 TMC6 WDR81 DIPK1B XK TMEM214 STING1 CYP2S1 RYR3 PIGQ NBAS TMC8 DISP3 UGT2B28 ALG6 MYMX SLC9A6 SLC27A2 | 2.37e-06 | 1299 | 116 | 22 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | NAT8L TAPT1 AUP1 DIPK1A PIEZO1 TMC6 WDR81 DIPK1B XK TMEM214 STING1 CYP2S1 RYR3 PIGQ NBAS TMC8 DISP3 UGT2B28 ALG6 MYMX SLC9A6 SLC27A2 | 3.36e-06 | 1327 | 116 | 22 | GO:0042175 |
| GeneOntologyCellularComponent | integrin alphav-beta5 complex | 3.05e-05 | 2 | 116 | 2 | GO:0034684 | |
| GeneOntologyCellularComponent | lamellipodium membrane | 2.37e-04 | 22 | 116 | 3 | GO:0031258 | |
| Domain | Pancreatic_hormone-like | 1.08e-04 | 3 | 113 | 2 | PD001267 | |
| Domain | PAH | 1.08e-04 | 3 | 113 | 2 | SM00309 | |
| Domain | Pancreatic_hormone-like_CS | 1.08e-04 | 3 | 113 | 2 | IPR020392 | |
| Domain | NNMT/PNMT/TEMT_CS | 1.08e-04 | 3 | 113 | 2 | IPR025820 | |
| Domain | PIP49_N | 1.08e-04 | 3 | 113 | 2 | PF14875 | |
| Domain | Pancreatic_hormone-like | 1.08e-04 | 3 | 113 | 2 | IPR001955 | |
| Domain | FAM69_N | 1.08e-04 | 3 | 113 | 2 | IPR029244 | |
| Domain | NNMT_TEMT_trans | 1.08e-04 | 3 | 113 | 2 | IPR000940 | |
| Domain | PANCREATIC_HORMONE_2 | 1.08e-04 | 3 | 113 | 2 | PS50276 | |
| Domain | Hormone_3 | 1.08e-04 | 3 | 113 | 2 | PF00159 | |
| Domain | PIP49_N | 1.08e-04 | 3 | 113 | 2 | SM01299 | |
| Domain | SAM_MT_NNMT_PNMT_TEMT | 1.08e-04 | 3 | 113 | 2 | PS51681 | |
| Domain | NNMT_PNMT_TEMT | 1.08e-04 | 3 | 113 | 2 | PF01234 | |
| Domain | PANCREATIC_HORMONE_1 | 1.08e-04 | 3 | 113 | 2 | PS00265 | |
| Domain | NNMT_PNMT_TEMT | 1.08e-04 | 3 | 113 | 2 | PS01100 | |
| Domain | FAT | 5.36e-04 | 6 | 113 | 2 | PS51189 | |
| Domain | FATC | 5.36e-04 | 6 | 113 | 2 | PS51190 | |
| Domain | FAD-bd | 5.36e-04 | 6 | 113 | 2 | IPR002938 | |
| Domain | FAT | 5.36e-04 | 6 | 113 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 5.36e-04 | 6 | 113 | 2 | IPR003151 | |
| Domain | FATC_dom | 5.36e-04 | 6 | 113 | 2 | IPR003152 | |
| Domain | PIP49_C | 5.36e-04 | 6 | 113 | 2 | PF12260 | |
| Domain | FAD_binding_3 | 5.36e-04 | 6 | 113 | 2 | PF01494 | |
| Domain | PIK_FAT | 5.36e-04 | 6 | 113 | 2 | IPR014009 | |
| Domain | FATC | 5.36e-04 | 6 | 113 | 2 | SM01343 | |
| Domain | FAM69_kinase_dom | 5.36e-04 | 6 | 113 | 2 | IPR022049 | |
| Domain | TMC | 9.92e-04 | 8 | 113 | 2 | PF07810 | |
| Domain | TMC | 9.92e-04 | 8 | 113 | 2 | IPR012496 | |
| Domain | - | 4.12e-03 | 16 | 113 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 4.12e-03 | 16 | 113 | 2 | SM00146 | |
| Domain | LRR_6 | 4.50e-03 | 55 | 113 | 3 | PF13516 | |
| Domain | ARM-type_fold | 4.56e-03 | 339 | 113 | 7 | IPR016024 | |
| Domain | PI3/4_kinase_cat_dom | 5.21e-03 | 18 | 113 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 5.21e-03 | 18 | 113 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 5.21e-03 | 18 | 113 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 5.21e-03 | 18 | 113 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 5.21e-03 | 18 | 113 | 2 | PS00916 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 23462327 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 12459484 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 27493116 | ||
| Pubmed | AlphaVBeta5 integrins mediates Pseudomonas fluorescens interaction with A549 cells. | 1.12e-05 | 2 | 117 | 2 | 24389192 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 10488139 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 34822124 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 11101640 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 23028753 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 37010292 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 26227733 | ||
| Pubmed | Crystal structures of human neuropeptide Y (NPY) and peptide YY (PYY). | 1.12e-05 | 2 | 117 | 2 | 35180645 | |
| Pubmed | Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation. | 1.12e-05 | 2 | 117 | 2 | 19706093 | |
| Pubmed | Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. | 1.12e-05 | 2 | 117 | 2 | 12426567 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 22761942 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 20238010 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 16885208 | ||
| Pubmed | β5 integrin is the major contributor to the αVintegrin-mediated blockade of HIV-1 replication. | 1.12e-05 | 2 | 117 | 2 | 21098231 | |
| Pubmed | Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants to cervical cancer susceptibility. | 1.12e-05 | 2 | 117 | 2 | 21387292 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 26126409 | ||
| Pubmed | The PepT1-NOD2 signaling pathway aggravates induced colitis in mice. | 1.12e-05 | 2 | 117 | 2 | 21762661 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 25378492 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 10844558 | ||
| Pubmed | Integrin alphavbeta5 is a primary receptor for adenovirus in CAR-negative cells. | 1.12e-05 | 2 | 117 | 2 | 20615244 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 14741360 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 7689573 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 20026907 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 23261238 | ||
| Pubmed | Tumor-penetrating therapy for β5 integrin-rich pancreas cancer. | 1.12e-05 | 2 | 117 | 2 | 33750829 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 18844213 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 19267182 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 27097911 | ||
| Pubmed | Novel role for alphavbeta5-integrin in retinal adhesion and its diurnal peak. | 1.12e-05 | 2 | 117 | 2 | 16338970 | |
| Pubmed | Merkel cell polyomavirus detection in a patient with familial epidermodysplasia verruciformis. | 1.12e-05 | 2 | 117 | 2 | 23535066 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 31239287 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 25406319 | ||
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | 3.07e-05 | 468 | 117 | 9 | 31056421 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 16373656 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 10537314 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 10552930 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 36976649 | ||
| Pubmed | MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4. | 3.36e-05 | 3 | 117 | 2 | 26876179 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 23534907 | ||
| Pubmed | Roles of integrins in human induced pluripotent stem cell growth on Matrigel and vitronectin. | 3.36e-05 | 3 | 117 | 2 | 19811096 | |
| Pubmed | The alphavbeta5 integrin functions as an endocytic receptor for vitronectin. | 3.36e-05 | 3 | 117 | 2 | 9443892 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 16675963 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 12270930 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 20719960 | ||
| Pubmed | Integrin and defensin modulate the mechanical properties of adenovirus. | 3.36e-05 | 3 | 117 | 2 | 23269786 | |
| Pubmed | Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing. | 3.36e-05 | 3 | 117 | 2 | 15611078 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 11162558 | ||
| Pubmed | Neuropeptide Y and peptide YY have distinct roles in adult mouse olfactory neurogenesis. | 3.36e-05 | 3 | 117 | 2 | 22354615 | |
| Pubmed | MerTK activation during RPE phagocytosis in vivo requires alphaVbeta5 integrin. | 3.36e-05 | 3 | 117 | 2 | 17249615 | |
| Pubmed | Neuropeptide Y and peptide YY protect from weight loss caused by Bacille Calmette-Guérin in mice. | 3.36e-05 | 3 | 117 | 2 | 23992467 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 16672769 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 26002416 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 19397935 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 19085950 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 18985734 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 22615249 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 22183400 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 18276918 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 20626753 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 22074485 | ||
| Pubmed | Characterisation of the FAM69 family of cysteine-rich endoplasmic reticulum proteins. | 3.36e-05 | 3 | 117 | 2 | 21334309 | |
| Pubmed | The human CIB1-EVER1-EVER2 complex governs keratinocyte-intrinsic immunity to β-papillomaviruses. | 3.36e-05 | 3 | 117 | 2 | 30068544 | |
| Pubmed | Zika Virus Targets Glioblastoma Stem Cells through a SOX2-Integrin αvβ5 Axis. | 3.36e-05 | 3 | 117 | 2 | 31956038 | |
| Pubmed | Targeting ανβ3 and ανβ5 inhibits photon-induced hypermigration of malignant glioma cells. | 3.36e-05 | 3 | 117 | 2 | 21978494 | |
| Pubmed | Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis. | 3.36e-05 | 3 | 117 | 2 | 22979996 | |
| Pubmed | NPY modulates PYY function in the regulation of energy balance and glucose homeostasis. | 3.36e-05 | 3 | 117 | 2 | 22369253 | |
| Pubmed | Structural basis for Y2 receptor-mediated neuropeptide Y and peptide YY signaling. | 3.36e-05 | 3 | 117 | 2 | 36525977 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 22566688 | ||
| Pubmed | Langerhans cell expression of neuropeptide Y and peptide YY. | 3.36e-05 | 3 | 117 | 2 | 12372697 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 32917726 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 22467244 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 37175535 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 21410462 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 11287419 | ||
| Pubmed | Autoregulation of insulin receptor signaling through MFGE8 and the αvβ5 integrin. | 3.36e-05 | 3 | 117 | 2 | 33903257 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 20519124 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 31757425 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 27899077 | ||
| Pubmed | Genetic determinants of disease progression in Alzheimer's disease. | 3.36e-05 | 3 | 117 | 2 | 25114068 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 16614246 | ||
| Pubmed | Cloning of human genes encoding novel G protein-coupled receptors. | 3.36e-05 | 3 | 117 | 2 | 7851889 | |
| Pubmed | CCN1 induces hepatic ductular reaction through integrin αvβ₅-mediated activation of NF-κB. | 3.36e-05 | 3 | 117 | 2 | 25822023 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 18158319 | ||
| Pubmed | 5.43e-05 | 504 | 117 | 9 | 34432599 | ||
| Pubmed | Regulation of membrane fluidity by RNF145-triggered degradation of the lipid hydrolase ADIPOR2. | 6.22e-05 | 63 | 117 | 4 | 35993436 | |
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 7525578 | ||
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 15866865 | ||
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 24294359 | ||
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 12196561 | ||
| Pubmed | Integrins αvβ5 and αvβ3 promote latent TGF-β1 activation by human cardiac fibroblast contraction. | 6.70e-05 | 4 | 117 | 2 | 24639195 | |
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 7682219 | ||
| Pubmed | The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. | 6.70e-05 | 4 | 117 | 2 | 10510291 | |
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 9849968 | ||
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 12356872 | ||
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 12657613 | ||
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 23227240 | ||
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 10921872 | ||
| Interaction | ST7 interactions | TAPT1 DSG2 AUP1 EVPL TMEM214 STING1 ST7L ITGAV NBAS P2RY6 SUN2 GSDMA | 8.29e-07 | 362 | 112 | 12 | int:ST7 |
| Interaction | ZNF610 interactions | 5.75e-06 | 7 | 112 | 3 | int:ZNF610 | |
| Interaction | C3orf52 interactions | NAT8L PIEZO1 TMC6 CYP2S1 ST7L ADCY6 NBAS TMEM245 SIGLECL1 SLC27A2 | 7.89e-06 | 305 | 112 | 10 | int:C3orf52 |
| Interaction | TTI1 interactions | 2.12e-05 | 101 | 112 | 6 | int:TTI1 | |
| Interaction | FKBP8 interactions | AUP1 TMEM214 CPZ STING1 TRRAP FBXL6 NBAS P2RY6 BNIPL LRRC61 PRKDC NUP160 | 4.54e-05 | 538 | 112 | 12 | int:FKBP8 |
| Interaction | TTYH1 interactions | 4.58e-05 | 300 | 112 | 9 | int:TTYH1 | |
| Cytoband | 14q31 | 2.29e-04 | 9 | 117 | 2 | 14q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | FFAR1 SIGLEC5 CYP2S1 PTGIR ZNF610 NTN5 ZNF766 ZNF528 SIGLECL1 KLK5 TDRD12 | 2.44e-04 | 1192 | 117 | 11 | chr19q13 |
| GeneFamily | Solute carriers | SLC10A4 SLC25A14 SLC16A4 SLC16A3 SLC15A1 SLC39A5 SLC9A6 SLC27A2 | 2.49e-04 | 395 | 76 | 8 | 752 |
| GeneFamily | Transmembrane channel likes | 4.80e-04 | 8 | 76 | 2 | 1135 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-08 | 163 | 117 | 8 | 8028636632c168dc50731d0ebecaf88a70daf81d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.01e-06 | 200 | 117 | 7 | 0eccf41edefc3b8b5d0316f57d5ba572949aec2b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal-BMP_responsible_cell|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.01e-06 | 200 | 117 | 7 | 01d707c4f8ee0daac635b7260937b1baebc6fc23 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.01e-06 | 200 | 117 | 7 | 5c638c80661017c85f9390f1b398ac7728c8f001 | |
| ToppCell | COVID-19_Moderate-MAIT|COVID-19_Moderate / disease group, cell group and cell class | 4.01e-06 | 159 | 117 | 6 | 6d08d670c34eb6bb8ad5dad3293b3107c006236d | |
| ToppCell | Control-NK|Control / Disease group and Cell class | 5.50e-06 | 168 | 117 | 6 | 683d389c8a1e791bfc773e63148115a21a6566db | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-06 | 171 | 117 | 6 | 7ca404539344e14dcd90c746c9122f713a7db78b | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-06 | 171 | 117 | 6 | ab113c8e773b0af47a87aed50e96be3ba71c3c82 | |
| ToppCell | Control-T/NK-NK|Control / Disease group,lineage and cell class (2021.01.30) | 7.66e-06 | 178 | 117 | 6 | 079fd19bdeed86bf985c4083af432432d66ad546 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-06 | 181 | 117 | 6 | 0756d7d315b8cdd07a3cf6cdfc8a0679786b8e6a | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-06 | 181 | 117 | 6 | b09947d2d7b21f96d98b87ceb6f467ea329c4092 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-06 | 181 | 117 | 6 | 3f0d88e9506d66d4e71b88c50d5187302065930f | |
| ToppCell | Control-Myeloid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.43e-06 | 181 | 117 | 6 | 25170e5285996cc80337d5f86a0255569861ae77 | |
| ToppCell | CTRL-Myeloid-cDC|CTRL / Disease state, Lineage and Cell class | 8.97e-06 | 183 | 117 | 6 | 20c4d16de7e090df3556a4458f783383a26871b6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-CD45____T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-06 | 184 | 117 | 6 | 2c8e9ddce3e60302965dcf9dee77c4fe33e4071d | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_A|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.55e-06 | 185 | 117 | 6 | 25781cf68e693e97dc1885e2879ab24fa946b51e | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Cycling_DC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.84e-06 | 186 | 117 | 6 | de1f0bc5dbf6dc0e716f5ebbf2bbcfe249811c54 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.01e-05 | 187 | 117 | 6 | 2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.11e-05 | 190 | 117 | 6 | ad297172a74a80ed5c10f921e15efd1da0fd2d6b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-05 | 190 | 117 | 6 | 07ea0578ca0561077557203ae660530f53fc4067 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-05 | 190 | 117 | 6 | 5b4b3eed7aa798bb7e3c5e968c8dc4144e377a5f | |
| ToppCell | Adult-Immune-monocyte-D175|Adult / Lineage, Cell type, age group and donor | 1.14e-05 | 191 | 117 | 6 | cbebb4d9550fdcd606cb3685ac9546c6b73fd422 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.36e-05 | 197 | 117 | 6 | 1ca06d6d288cb58a6e8062ebc01831e58ee5be4b | |
| ToppCell | normal_Lung-Endothelial_cells-EPCs|Endothelial_cells / Location, Cell class and cell subclass | 1.36e-05 | 197 | 117 | 6 | bfdde765bf05c5bff88bc3ab5175bfe61e79ed60 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.36e-05 | 197 | 117 | 6 | 61f909737c5f630beffdd326c6844215643dbdde | |
| ToppCell | Biopsy_IPF-Immune-pDCs|Biopsy_IPF / Sample group, Lineage and Cell type | 1.40e-05 | 198 | 117 | 6 | aa8943e6796f619406056cf763b751fe9a9a3e0c | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Myeloid-Microglia|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.40e-05 | 198 | 117 | 6 | 901cd39cb84f1907f2f5d27221979c854bd3b40e | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Myeloid|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.40e-05 | 198 | 117 | 6 | cc292aa8518d5ef8940e2327f2f07d584a996d90 | |
| ToppCell | distal-2-Hematologic-Plasmacytoid_Dendritic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.44e-05 | 199 | 117 | 6 | 78796b05d28b35e7361b6271d4a3858faa39c45c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.49e-05 | 200 | 117 | 6 | fe22f7c97f4e37dfa7881d0f1d9245c1237d873b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.49e-05 | 200 | 117 | 6 | 25f4c051c2e869481f33c22ad54de97efac444ad | |
| ToppCell | healthy_donor|World / Disease condition, Lineage, Cell class and subclass | 1.49e-05 | 200 | 117 | 6 | afd4d5609adaa470e3d880f8be4a4d55e162b3d6 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal-BMP_responsible_cell|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.49e-05 | 200 | 117 | 6 | 604a88633d4162337e394155c7346dbdef8b9f5a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-BMP_responsible_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.49e-05 | 200 | 117 | 6 | 26251ed8c7fa7e87973d6f59bd398c88ad025395 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial-Proteoglycan-expressing_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.49e-05 | 200 | 117 | 6 | da45a85a4667965b24ba824af871157af5b4cd19 | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Blood_Derived_Cancer_-_Peripheral_Blood-Leukemia-Acute_Myeloid_Leukemia-7|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 4.07e-05 | 145 | 117 | 5 | 88090a226ddfa6df59976f025bf0fd84ca0f72ef | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lcn2_(Vwf)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.34e-05 | 74 | 117 | 4 | 0288a3f4eafbc359d01cde4ba58f946dd07c77cb | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.34e-05 | 74 | 117 | 4 | 57884ade66fe39398351685189df5efd7aea0aab | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lcn2_(Vwf)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.34e-05 | 74 | 117 | 4 | 13093139a75bfe11f6b032c9fb402efcc703551c | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lcn2_(Vwf)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.34e-05 | 74 | 117 | 4 | 7f7de9e8142d2435391ee965cee5628e412f0705 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.78e-05 | 150 | 117 | 5 | b6f1fc62d08199fed6156c7cd32f66d9926531b5 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.09e-05 | 152 | 117 | 5 | 32634195048858ae84605c61e43c542d90f7cab5 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.09e-05 | 152 | 117 | 5 | 0eb185b2404f015efff1bd140e0c502d714720fb | |
| ToppCell | Control-Myeloid-Neutrophils|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.25e-05 | 153 | 117 | 5 | c33d63b2d1a220bc428e776b157b23faa43ea8ca | |
| ToppCell | Control-Myeloid-Neutrophils-Neutrophils|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.25e-05 | 153 | 117 | 5 | e3630f2b10f33092a3b6a63dba3a39fbdecbc7bd | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-3|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.76e-05 | 156 | 117 | 5 | b464871ad7c8ce0d58013a27996639eac1e526d8 | |
| ToppCell | severe_influenza-NK_CD56bright|severe_influenza / disease group, cell group and cell class (v2) | 5.94e-05 | 157 | 117 | 5 | fabaf54429dd5a899f9192f0d42522109ca36b9b | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD1c+_DCs|metastatic_Brain / Location, Cell class and cell subclass | 6.30e-05 | 159 | 117 | 5 | 35a63ca521635389a1edc7c81157793b8ad24d38 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.30e-05 | 159 | 117 | 5 | 24f87c666eff10c1844c900ffd7ad49fa9f80481 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.69e-05 | 161 | 117 | 5 | 2849fbc9611af208241b33da3cd18290aafe426b | |
| ToppCell | frontal_cortex-Non-neuronal-macrophage|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.09e-05 | 163 | 117 | 5 | b89f586b444f90047c8ce407f53847fd1ee7cca3 | |
| ToppCell | frontal_cortex-Non-neuronal-macrophage-Macrophage|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.09e-05 | 163 | 117 | 5 | cbe9b4c4b2e42e9f92a57ed66758af93434db5bb | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.30e-05 | 164 | 117 | 5 | 95b800c78871354c859abaa832d778786ef7bcc0 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 7.51e-05 | 165 | 117 | 5 | 7d319a112b9062efee428bef6f4534d2ce782e04 | |
| ToppCell | NS-critical-d_07-13-Myeloid-pDC|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.51e-05 | 165 | 117 | 5 | 17d5c4a111d9b5400780bc5e7b93ce2f5d69ceb7 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.51e-05 | 165 | 117 | 5 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.51e-05 | 165 | 117 | 5 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.51e-05 | 165 | 117 | 5 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-Tmem119|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.73e-05 | 166 | 117 | 5 | 063d68f2ffb40770cb4601fa1cb6426ae26f7a37 | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Junb_(Microglia)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.73e-05 | 166 | 117 | 5 | 417cfb207da08fa1a0fd5f2a13c8786628667a8e | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Junb_(Microglia)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.73e-05 | 166 | 117 | 5 | f28d07715e6b00ca2a0df39273c5f569744be5a8 | |
| ToppCell | NS-moderate-d_07-13-Myeloid-pDC|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.18e-05 | 168 | 117 | 5 | d03e91f0e0518b33555c0ec98124fc5ed0f11be5 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.18e-05 | 87 | 117 | 4 | f92e08c2d1c2f216063ecfd42b06652e558c1a89 | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 8.41e-05 | 169 | 117 | 5 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD1c+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 8.65e-05 | 170 | 117 | 5 | 403b6b749d70d845838dcda7daf99971b50792a2 | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 8.65e-05 | 170 | 117 | 5 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.13e-05 | 172 | 117 | 5 | ef33b5e0515c6d29fb6d9a673011c1b68ef264f3 | |
| ToppCell | facs-Skin-nan-24m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.64e-05 | 174 | 117 | 5 | 6863222bec844f40c0c80f5c82a8ff51d1a56d0a | |
| ToppCell | facs-Skin-nan-24m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.64e-05 | 174 | 117 | 5 | 5739c1b8d643ad360ef32049832d749c530ca603 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.64e-05 | 174 | 117 | 5 | 1b2a2129c08bac01fc638692313b196759a1e0d7 | |
| ToppCell | facs-Skin-nan-24m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.64e-05 | 174 | 117 | 5 | d570eab215f8287362084e37f35672e20aa0f7a2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.64e-05 | 174 | 117 | 5 | 5bde24eb588dc588efc413811379548120ec0c7f | |
| ToppCell | mild_COVID-19-pDC|mild_COVID-19 / disease group, cell group and cell class (v2) | 9.91e-05 | 175 | 117 | 5 | b87f279a7519710146c49d6acccb0adedc195965 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.91e-05 | 175 | 117 | 5 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 176 | 117 | 5 | 2e1003dc373b14d27f0464d980453fdcfc1005f0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 176 | 117 | 5 | 274458d80f9f3f080248cbf64e4784ef351e7254 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 176 | 117 | 5 | 238244294d08975df6bfa26b2b437db3654408ae | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 176 | 117 | 5 | d0a3e176df1270968efa79c00dc941c5e1c4f7aa | |
| ToppCell | Dendritic_Cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.05e-04 | 177 | 117 | 5 | d2cd081bdda0eba9f6f6473c4d3939e4bee3440e | |
| ToppCell | Control-Myeloid-pDC|Control / Disease state, Lineage and Cell class | 1.05e-04 | 177 | 117 | 5 | 3940663bb5b45b2ca9f772550380a516c53e410b | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_Exhausted-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.05e-04 | 177 | 117 | 5 | 28f2ea29a52de90301e6ba770f407ee4034936d5 | |
| ToppCell | Control-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 1.05e-04 | 177 | 117 | 5 | e82115bfc32c7b689460fbc5caeb983c1aabe30f | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_Exhausted|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.05e-04 | 177 | 117 | 5 | f87bbc9403e909bb534eb705bcd2bca83d072cc7 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 178 | 117 | 5 | 09a215a0d6e98e4bb920cabda12af08ff4de3c98 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-04 | 179 | 117 | 5 | c9f45cfea0ceb0cdc31bcfd123aeab69aeb35c35 | |
| ToppCell | Control-Myeloid-Monocytes,_Macrophages|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-04 | 179 | 117 | 5 | a79a244bf8ecc333d034b2eb2de554d3310ca6de | |
| ToppCell | Control-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-04 | 179 | 117 | 5 | c4ff8b191ed0f6dc2dd784869f6f2c62e170a7db | |
| ToppCell | RSV-Healthy-0|RSV / Virus stimulation, Condition and Cluster | 1.13e-04 | 180 | 117 | 5 | 974044056e2f7e909cb11c6f6ca89e58bf95f7e5 | |
| ToppCell | moderate-Myeloid-pDC|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.13e-04 | 180 | 117 | 5 | a0751ad5e42a21cb107d900abfa9ee967a0069fc | |
| ToppCell | NS-moderate-d_16-33-Myeloid-pDC|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.13e-04 | 180 | 117 | 5 | 144818e69613296cde43f29cb8c20899c670b319 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 180 | 117 | 5 | 18bf8561ad3aa9787d2a8ef942a96f641734c608 | |
| ToppCell | Adult-Immune-T_lymphocyte-D122|Adult / Lineage, Cell type, age group and donor | 1.13e-04 | 180 | 117 | 5 | 06c371d0f0c5a7b234dd143e98800e19af95a8b5 | |
| ToppCell | RSV-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | 1.13e-04 | 180 | 117 | 5 | 703a1d0f9536af94d56757eb01221878d7b7fe61 | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-pDC|Lung / Manually curated celltypes from each tissue | 1.16e-04 | 181 | 117 | 5 | 3d7f089fb434fbc989f1fa159e22133ae00b2487 | |
| ToppCell | COVID-19-kidney-Mito-rich_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.16e-04 | 181 | 117 | 5 | 8448c2ad560cfd48bfe9dc1dd3a64373e6a622dd | |
| ToppCell | CTRL-Myeloid-cDC|Myeloid / Disease state, Lineage and Cell class | 1.19e-04 | 182 | 117 | 5 | ee137574b8f0e684a4a7cb26226877c471cae433 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-SC_&_Eosinophil|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.19e-04 | 182 | 117 | 5 | 6bd6c32c48fecd6d03ac8a09e405b3b99bdc12ae | |
| ToppCell | COPD-Myeloid-Mast|World / Disease state, Lineage and Cell class | 1.19e-04 | 182 | 117 | 5 | 68a1e7b804f309bfd6c23d65fad20a9a962712ae | |
| ToppCell | Control-Lymphocytic_NKT-iNKT/MAIT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-04 | 183 | 117 | 5 | 59e8d07556390828f7557ba3fd2f7d49851498b7 | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.22e-04 | 183 | 117 | 5 | 9840706f972387241bf1d4ba8af25efc3214a91b | |
| Computational | Genes in the cancer module 71. | 8.73e-06 | 22 | 66 | 4 | MODULE_71 | |
| Computational | Genes in the cancer module 500. | 3.15e-05 | 30 | 66 | 4 | MODULE_500 | |
| Computational | Genes in the cancer module 218. | 2.34e-04 | 20 | 66 | 3 | MODULE_218 | |
| Computational | Neighborhood of MATK | 4.08e-04 | 24 | 66 | 3 | GNF2_MATK | |
| Disease | EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1 | 1.53e-05 | 2 | 116 | 2 | C4722564 | |
| Disease | epidermodysplasia verruciformis (is_implicated_in) | 1.52e-04 | 5 | 116 | 2 | DOID:13777 (is_implicated_in) | |
| Disease | Epidermodysplasia Verruciformis | 1.52e-04 | 5 | 116 | 2 | C0014522 | |
| Disease | Trypanosoma cruzi seropositivity | 3.18e-04 | 7 | 116 | 2 | EFO_0005530 | |
| Disease | childhood absence epilepsy (is_implicated_in) | 4.22e-04 | 8 | 116 | 2 | DOID:1825 (is_implicated_in) | |
| Disease | Peripheral Nervous System Diseases | 1.27e-03 | 54 | 116 | 3 | C4721453 | |
| Disease | Global developmental delay | 1.91e-03 | 133 | 116 | 4 | C0557874 | |
| Disease | Anorexia | 2.25e-03 | 18 | 116 | 2 | C0003123 | |
| Disease | nevus count | 2.25e-03 | 18 | 116 | 2 | EFO_0004632 | |
| Disease | Systemic Scleroderma | 2.51e-03 | 19 | 116 | 2 | C0036421 | |
| Disease | Severe Combined Immunodeficiency | 2.78e-03 | 20 | 116 | 2 | C0085110 | |
| Disease | asthma | 2.90e-03 | 751 | 116 | 9 | MONDO_0004979 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SGLALARCGLNPVLY | 296 | P46092 | |
| LGACLVLLQSGYKIP | 1371 | Q9P2K9 | |
| LGLLRLCLAQANFAP | 11 | Q96JP9 | |
| NALCILLYPGLILID | 146 | Q9Y672 | |
| GAARLCLLAFALQPL | 6 | Q9H013 | |
| PQPAYVALLACAAAL | 176 | O43306 | |
| PRLCALYAGLSLLQQ | 426 | Q96QA5 | |
| AVLLLLAGLYRGQAL | 381 | P22455 | |
| LYLNLESCRCLPRGL | 501 | Q8N531 | |
| LLGLLPAAYLNPCSA | 76 | O14521 | |
| LAKVCALLRGYLLPG | 366 | Q5VUD6 | |
| CFLAPDNSLLLARYL | 546 | A2RUS2 | |
| LTALLLTCPGALQAY | 351 | Q6ZUJ8 | |
| LALLVCLGALVDAYP | 16 | P10082 | |
| FGPLVLLCYALRLNF | 156 | Q8NGL3 | |
| LLCYALRLNFSGPNV | 161 | Q8NGL3 | |
| LAALCQFGLLPLLAF | 141 | Q96EP9 | |
| GRAYALLLLLICFNV | 6 | Q14126 | |
| YLGLCAALEPILSAK | 356 | Q5VWQ8 | |
| LAGLACAPIKINIIY | 186 | Q8NGH9 | |
| YRAALCNLASLLKPG | 176 | O95050 | |
| CALSPLGQLLQDRYG | 161 | O15427 | |
| QCLAGLPCLEYLRLR | 116 | Q9BV99 | |
| YPLLLCLLLAQLGLG | 6 | Q5T848 | |
| ALLGCSKYAELLLIP | 2521 | Q15751 | |
| GLNAVILFASCYLPR | 211 | Q7Z465 | |
| LLGNLLQLRPGALYS | 41 | Q96SQ9 | |
| LLAYLLALAAPGRGA | 21 | O60486 | |
| FPLCSLYLIAVLGNL | 31 | Q8TCB6 | |
| CLLLPAARLARQYLL | 16 | A0A1B0GTQ4 | |
| LTKALRYLQQPGCLL | 181 | A6NDG6 | |
| CAVRAGLLRPDYALL | 506 | Q96PD5 | |
| YCRALRNLGSLLKPG | 176 | P40261 | |
| SGLLLLPAALEGYRC | 2006 | Q92817 | |
| LALCALVYRLQPGLL | 541 | Q8TDZ2 | |
| CLDLVNKRLPYGLAQ | 196 | Q9UHN1 | |
| QAALLLRPNQLYCGA | 81 | Q9Y337 | |
| CQGAASRPAILYALL | 11 | Q15466 | |
| APLYACLLGLCALLP | 6 | P18084 | |
| AYLLALPQVLDANRC | 1546 | A2RRP1 | |
| LLSLLLPLEQNECYL | 511 | Q96MC2 | |
| ASYLCFRLLGAALPL | 301 | Q9BQG0 | |
| AQAPGLYQRLSLCTL | 106 | Q8N6F8 | |
| LYQRLSLCTLGQEPL | 111 | Q8N6F8 | |
| ALALCLGKPADVYLI | 471 | P61221 | |
| VNLCSPYLLLRRAVL | 1071 | Q86XA9 | |
| CSEYLLGNPRIQRLL | 266 | Q66K79 | |
| LPILLNERLQTGSYC | 671 | Q8NF50 | |
| LRLTPSLVYALNLGC | 36 | O14842 | |
| ERSLPLCLQLYAPGL | 156 | P13284 | |
| AQSFGLLDPKLCYLL | 21 | P20963 | |
| SGLLLPLCRAFNLDV | 21 | P06756 | |
| LGCLHLLYFLLRQPQ | 206 | P04180 | |
| ALPLALLCNGKNYSL | 4906 | Q8NDH2 | |
| LLDPYVNLAPGCRSL | 676 | Q5W0V3 | |
| LLKLLACGPLGYIRN | 841 | O95180 | |
| LLLCALLAPGGAYVL | 31 | P54803 | |
| ACQLLKDYLLRGAPS | 366 | Q5T7M9 | |
| ALCYLTPILGALIAD | 61 | P46059 | |
| LGRLDACSTVLPLYA | 176 | Q9H228 | |
| RYLVNDACVLAGRPL | 186 | O95396 | |
| LNLALADLLYACSLP | 66 | Q15077 | |
| FPICLLLASYQGILR | 196 | Q15743 | |
| CPLRRGALLLLSIYF | 91 | Q86WV6 | |
| AANIYPLSLLLNLGR | 426 | Q92581 | |
| ALLLLLGQATADPCY | 6 | Q8WTR8 | |
| GLLFLPLLVNLCCPY | 11 | O14975 | |
| PYSLLRLLACQSLLF | 551 | Q587J7 | |
| INSLPLYSLGLRLCR | 491 | Q9BRB3 | |
| QRSSLAPGLPACLYL | 131 | Q6ZUM4 | |
| LAALCFGLAALYAPV | 86 | Q587I9 | |
| YAGIVIALLFLCLLP | 121 | Q8N7X8 | |
| YLPVLEGQALRLLCD | 256 | O15389 | |
| CPLDRAYLIKLSGLN | 61 | Q9Y5N6 | |
| SYCGPAILRFRQLLA | 91 | Q7Z3Z2 | |
| LAALNCLRLIRPEYA | 1126 | Q12769 | |
| LTPRQFALLCPALLY | 176 | Q6ZMH5 | |
| GLAFLNSCLNPILYV | 291 | P46091 | |
| QELCAGALQLLGYRP | 346 | Q9GZX3 | |
| EPVRRQGNYLLCSLL | 306 | Q9H8M5 | |
| DCFLLLVLLLYAPVG | 21 | Q9Y679 | |
| NYRNLVFLGICLPDL | 56 | Q8N9Z0 | |
| LQLLCGLLAGLAYAA | 166 | Q9Y3P4 | |
| LSLLLIPAAAGTYCE | 21 | A6NLX4 | |
| LALYSGIAPALLRQA | 101 | O95258 | |
| CPVSYLLLCGQAALL | 6 | Q9BX73 | |
| IRLAYLLSPLACLLL | 201 | Q8IU68 | |
| LGAFLCPALVYTNLI | 651 | Q9NZQ8 | |
| SYLILCGITNLLAPL | 371 | O15374 | |
| LPCLGVCKALYLRDN | 811 | Q9HC29 | |
| FLLPLLLLTCLTYGA | 216 | Q9UH99 | |
| CAALLRRQTSGPLYL | 16 | Q5VYX0 | |
| LYAQLDGPRCARLAL | 126 | P43119 | |
| AVPLLLLLCFGSQRA | 6 | Q9BQR3 | |
| LALNRYICSAVLPLL | 2411 | Q15413 | |
| LSLLVCLGALAEAYP | 16 | P01303 | |
| QLCQLYPRLKVLAFG | 341 | Q6NUQ4 | |
| RLCLLILLPLYSGLQ | 256 | Q86WB7 | |
| LALRSLQNRCLVPGY | 741 | P52849 | |
| VALPLALLGLYPALC | 611 | C9JH25 | |
| GLLYALRIPLRLCEN | 51 | Q8TDW4 | |
| CQGSLIAAYLLLPLG | 36 | Q8N6L7 | |
| LLYLRGPFSLQATLC | 1241 | P78527 | |
| GNCLLPAQLVLREYF | 171 | P21506 | |
| LAALLLPLCFVDYGV | 121 | Q9H330 | |
| AANPLLLTGAYILLA | 46 | Q96SJ8 | |
| YRNLVSLGICLPDLS | 41 | Q3MIS6 | |
| LALFRLLTLPCYGLR | 136 | Q6NXT6 | |
| LLNLGAPYLCRVLAA | 481 | Q7Z403 | |
| PGVLLLLCYATASLR | 316 | Q92508 | |
| NYRNLVSLGICLPDL | 41 | Q5HY98 | |
| CGELLAALLNIPFVY | 156 | Q9BY64 | |
| AILQAGGLADCLLYL | 556 | Q14669 | |
| RIAALNALAACNYLP | 1366 | Q9Y4A5 | |
| PAGAYNLLLCLASRA | 866 | Q08AF3 | |
| VCAPLLVLQLLIGYC | 346 | P51811 | |
| ARNLLRLLTSCYVGP | 1246 | Q562E7 | |
| LPILTQCASLRYLGL | 386 | Q15048 | |
| LLTCLVPAALLGLRY | 136 | Q8N9F0 |